| 标题 |
 Interim analysis of the phase II study of glofitamab, lenaliomide and venetoclax (GLOVe) in untreated patients w/ high-risk mantle cell lymphoma. response and safety outcomes after the completion of stage 1 of 2 enrollment |
| 网址 | |
| DOI |
10.1182/blood-2025-883
doi
|
| 其它 |
期刊：Blood 作者：Tycel Phillips; Lu Chen; Tiffanie Barnhizer; Alex Herrera; Geoffrey Shouse; et al 出版日期：2025-12-05 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
null
DW
OK
极限001
huang
123
aajhajkahna
aaaa
乐空思
baa
xing_xing
七听
秋风
吃葡萄不吐葡萄皮
Youdge
秦艽
pluto
Nole
zfz
皖公网安备34019202002308
